Chimera Peptides
Tirzepatide
Finnrick tested 7 samples of Tirzepatide (GLP-1 and GIP agonist) from Chimera Peptides between 29 Dec 2025 and 23 Apr 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).
Finnrick Rating™
Chimera Peptides
Tirzepatide
Tested 7 Samples
Last test 23 Apr 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Chimera Peptides
Samples are tested in commercial labs
Tests Count
7
Scores
AVGMINMAX
Last
23 Apr 2026
First
29 Dec 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 23 Apr 2026 | View | 30mg | 30.7mg | +2.3% | 99.90% | (no batch ID) | White Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 2 Apr 2026 | View | 30mg | 32.1mg | +7.0% | 99.70% | 2026-02-20 | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 10 Mar 2026 | View | 30mg | 28.9mg | -3.7% | 99.90% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 5 Mar 2026 | View | 60mg | 64.4mg | +7.3% | 99.80% | (no batch ID) | White Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 18 Feb 2026 | View | 30mg | 32.7mg | +9.0% | 99.63% | (no batch ID) | No Label / Silver Crimp / Orange Cap | Lab E | Public | |
| 2 Feb 2026 | View | 30mg | 31.6mg | +5.3% | 99.21% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 29 Dec 2025 | View | 20mg | 25.7mg | +28.5% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |